Navigation Links
Bone Care bought for $600 million; Wisconsin Angel Network launches

Bone Care, a UW-Madison spinoff that develops a drug for kidney-disease patients, is being acquired for $600 million. The buyer? Massachusetts-based Genzyme, a multi-billion-dollar biotech. Also: the Wisconsin Angel Network gives entrepreneurs and angel investors a new way to find each other, and UW-Madison reviews desktop search engines.

Original air date: Saturday, May 7, 2005



Source:wistechnology.com By Mike Klein 05/06/05


Page: 1

Related biology technology :

1. Camtronics Medical Systems is bought by Alabama company
2. Criticare narrows loss, but sales drop after partner is bought
3. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
4. Federal bioenergy lab will give Wisconsin a chance to shine
5. Breaking down Wisconsins angel capital numbers
6. Innovation featured in NE Wisconsin Roundtable
7. Visions: Broderick says Wisconsin should be in top third in venture capital
8. Wisconsin building toward the major leagues of venture capital
9. Wisconsin Supreme Court to hear Menasha software case
10. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
11. Legislature should look to Wisconsins natural energy advantages
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bone Care bought for million Wisconsin Angel Network launches

(Date:9/16/2014)... Longmeadow, MA (PRWEB) September 16, 2014 ... appointment of Brian Highley as CEO of CIRTEC. ... this exciting point for the Company.” noted Brian Highley. ... operational performance while sustaining strong organic growth over the ... CIRTEC’s growth by continuing to improve and expand the ...
(Date:9/16/2014)... N.C. , Sept. 16, 2014  The ... oldest entrepreneurial support organization in the country, today ... Innovators Report . It showed ... North Carolina startups in the ... drew more global investment from a variety of ...
(Date:9/16/2014)... 2014   Synthetic Biologics, Inc. (NYSE ... biologic and drug programs targeting specific pathogens that ... of the Company,s Investor Day in ... bowel syndrome (IBS) program, including its novel, oral ... In the keynote presentation, Mark Pimentel , ...
(Date:9/16/2014)... Pharma Packaging Solutions announced ... for their 89th year in business. Adding ... Packaging Solutions is preparing packaging operations changes ... new procedures. Establishing training and system validation ... Pharma Packaging Solutions will be ready to ...
Breaking Biology Technology:CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 2Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day 3Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2
... Incorporated (Nasdaq: SPEX ), an innovator in ... and providers of technical and regulatory consulting services to ... its President, Dr. Robert Lodder, will be presenting at ... Dr. Lodder will deliver the Company,s corporate presentation ...
... IRVING, Texas, Jan. 5, 2011 Signal Genetics, the ... predictive genetic testing company focused on oncology, and Caris ... enabling precise and personalized healthcare through the highest quality ... announced a new agreement under which Caris Life Sciences ...
... Corporation (Nasdaq: VRNM ), a pioneer in ... today announced that James Levine, Executive Vice President and ... Jaffray Sixth Annual Clean Technology & Renewables Conference.  The ... on Wednesday, January 12, 2011 and will take place ...
Cached Biology Technology:Spherix to Present at Two Upcoming Prominent Finance Conferences 2Spherix to Present at Two Upcoming Prominent Finance Conferences 3Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test 2Signal Genetics and Caris Life Sciences Announce Commercialization Partnership for New Myeloma Gene Expression Test 3Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference 2Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference 3
(Date:9/15/2014)... both plants and animals alike. , Understanding just how ... to the design of better drugs for diabetes patients ... vegetables farmers are able to grow. Stanford University researchers ... cell by piecing together proteins slightly wider than the ... determine the size, shape and orientation of one of ...
(Date:9/15/2014)... have found "the most famous wheat gene," a reproductive ... transfer valuable genes from other plants to ... develop wheat varieties with the disease- and pest-resistance traits ... that can reduce crop losses and pesticide use while ... Modified Organisms, or GMOs., "The real exciting part of ...
(Date:9/15/2014)... WASHINGTON A new strategic vision document, released ... Research Program, describes the long-term goals, objectives, and ... scope of work over the next five years ... its initial, short-term activities, to be funded in ... and science policy fellowships. , The $500 ...
Breaking Biology News(10 mins):X-rays unlock a protein's SWEET side 2X-rays unlock a protein's SWEET side 3WSU researchers find 'most famous wheat gene' 2NAS Gulf Research Program announces strategic vision, initial opportunities 2NAS Gulf Research Program announces strategic vision, initial opportunities 3NAS Gulf Research Program announces strategic vision, initial opportunities 4
... producing proteins that moonlight, having different roles at different ... killed. The moonlighting activity of one enzyme from the ... of broad-spectrum antibiotics, according to a paper published in ... "Glutamate racemase, or MurI, is an enzyme ...
... many recent reports documenting the therapeutic efficacy of short ... may actually be describing non-specific therapeutic effects related to ... according to a paper in the September 2008 issue ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... NY, Sept. 2, 2008) People concerned about the ... families and communities will have a unique opportunity to ... about the causes, symptoms and progression of such illnesses ... learn about current and potential treatments. In an ...
Cached Biology News:Energy-saving bacteria resist antibiotics 2Previous claims of siRNA therapeutic effects called into question by report in human gene therapy 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3
Applications: Western blotting ...
...
... efficiencies and the chemistry of light production ... benefit that they require simple triggering conditions ... This benefit has been exploited to great ... compounds can also be easily modified to ...
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
Biology Products: